MihaelaDrutaMD

Oncology • Tampa, FL

Hematologic Oncology, Sarcoma

Hematology/Oncology/Sarcoma Medical Oncologist

Join to view full profile

Dr. Druta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Druta's full profile

Already have an account?

Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Phone+1 813-745-3242

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Sarcoma Medical Oncology/ Willie Tichenor Sarcoma Fellowship, 2012
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2009 - 2012
University of South Florida MorsaniResidency, Internal Medicine, 2006 - 2009
Carol Davila University of Medicine and PharmacyClass of 1999

Certifications & Licensure

FL State Medical License 2009 - 2026
TX State Medical License 2012 - 2013
American Board of Internal Medicine Medical Oncology

Clinical Trials

Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
Completed
Phase 2
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01
Completed
Phase 3
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
Active, not recruiting
Phase 3
Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery Start of enrollment: 2019 Dec 31
Active, not recruiting
Phase 2
Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma Start of enrollment: 2016 Dec 06
Completed
Phase 2
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08
Active, not recruiting
Phase 3
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Start of enrollment: 2019 Aug 13
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma.
John Michael Bryant, Matthew N Mills, Casey Liveringhouse, Russell Palm, Mihaela Druta
Radiotherapy and Oncology. 2024-11-19
Radioembolization of Primary Splenic Angiosarcoma Complicated by Delayed Gastric Hemorrhage.
Aditya Garg, Luis Pena, Gregory Y Lauwers, Mihaela Druta, Bela Kis
Journal of Vascular and Interventional Radiology. 2024-09-30
14 citations
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, Mark Agulnik, Steven Attia
Lancet. 2024-04-13